Monday, April 6, 2026

Akari partners with WuXi XDC to support AKTX-101 IND by late 2026

 

Akari Therapeutics announces strategic development and manufacturing partnership with WuXi XDC to support AKTX-101 IND by late 2026

  • Partnership aims to advance Akari's novel PH1 ADC payload and lead candidate AKTX-101 toward clinical development.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.